{"disease":{"id":"advanced-stage-iiib-c-iv-ovarian-primary-peritoneal-and-fallopian-tube-cancer","name":"advanced stage iiib c iv ovarian primary peritoneal and fallopian tube cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03462212","title":"Carboplatin-Paclitaxel-Bevacizumab vs Carbo-Pacli-Beva-Rucaparib vs Carbo-Pacli-Ruca, Selected According to HRD Status, in Patients With Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer, Preceded by a Phase I Dose Escalation Study on Ruca-Beva Combination","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":290,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}